Part 2 IRBs & Ethics Committees
This is the second in a series of podcasts specifically dedicated to how good clinical research on pharmaceutical products is planned, conducted, analyzed and approved. Given the recent Plandemic and Covid-19 "vaccine" rollout including mandates for...
An episode of the Pharma to Dharma podcast, hosted by Dr Joanna Carmichael, titled "Part 2 IRBs & Ethics Committees" was published on June 12, 2024 and runs 36 minutes.
June 12, 2024 ·36m · Pharma to Dharma
Summary
This is the second in a series of podcasts specifically dedicated to how good clinical research on pharmaceutical products is planned, conducted, analyzed and approved. Given the recent Plandemic and Covid-19 "vaccine" rollout including mandates for people to either get vaxed or lose their jobs, livelihoods, and in some cases, their families, and businesses, I wanted to create a series that would educate people on the process of clinical research - how a new drug gets to market, so that they could make more informed decisions about what they will and will not choose to put in their bodies. Informed Consent is the first and most important part of the process given that patients were basically put in a drug study without their informed consent if they took the Covid-19 "vaccine". Episode #2 is on IRBs and Ethics Committees which is the second most important part of the process of Clinical Research where an independent body of people review the study protocol, Informed Consent, and Investigator’s Brochure for ethics and inclusion of key elements and determines approval to enroll patients so their safety is guarded and rights are not violated.https://www.linkedin.com/in/b-michele-commins-2a07715/https://vedicalchemy.org/resourceshttps://vedicalchemy.org/products-%26-faqshttps://vedicalchemy.org
Episode Description
https://www.linkedin.com/in/b-michele-commins-2a07715/
https://vedicalchemy.org/resources
https://vedicalchemy.org/products-%26-faqs
https://vedicalchemy.org
Similar Episodes
Apr 15, 2025 ·31m
Mar 21, 2025 ·39m
Feb 18, 2025 ·42m